News | Mammography | November 10, 2015

Flat panel display can now be used for 3-D mammography, breast MRI and ultrasound

Barco, Coronis Uniti, clearance, multimodality breast imaging

Image courtesy of Barco


November 10, 2015 — Healthcare imaging specialist Barco announced in October that its flagship diagnostic display system, Coronis Uniti, has been clinically validated for multimodality breast imaging. This makes Coronis Uniti the world’s first and only diagnostic display that can be used for both picture archiving and communication systems (PACS) and multimodality breast imaging, including breast tomosynthesis, 3-D mammography, breast magnetic resonance imaging (MRI) and breast ultrasound.

The system had previously been cleared for viewing PACS and mammography images, including breast tomosynthesis. The U.S. Food and Drug Administration’s (FDA) new indications for use include breast MRI, breast ultrasound, computed tomography (CT) and ultrasound, including vascular and gynecological ultrasound. This enables radiologists to view a host of breast imaging modalities – in color or grayscale, 2-D or 3-D, static or dynamic – on a single display. 

The ability to access any image on a single display offers significant benefits, from workflow and clinical perspectives. First of all, it eliminates the need to change workstations to complete patient studies. Additionally, running side-by-side comparisons and image fusions have proven to positively impact diagnostic interpretation. The use of ultrasound in combination with conventional mammography in women with dense breasts, for example, has resulted in better early breast cancer detection

Differences in the visual appearance of different image types posed additional challenges, which Barco tackled by introducing proprietary technologies to automatically set the proper color and grayscale settings for every image modality – even when viewing them simultaneously on the screen. 

Barco also found a way to counteract motion blur when reviewing multi-frame image sequences such as digital breast tomosynthesis, breast ultrasound and breast MRI. Thanks to RapidFrame technology, which provides a high pixel refresh rate, Coronis Uniti enables radiologists to accurately visualize moving and changing images, avoiding loss of detail when scrolling through the 3-D stack and ensuring efficient diagnosis as well as swift workflow. 

For more information: www.barco.com


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | RSNA

Jan. 22, 2026 — The nomination deadline for the 2026 RSNA Rising Star Award is approaching. The Rising Star Award is ...

Time January 22, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
Subscribe Now